company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1416000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1373000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2789000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2789000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-803000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-803000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3592000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3592000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3592000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,138000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3730000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,964880.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q3,2012-07-01,2012-09-30,2013-12-05 16:16:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1466000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3155000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4621000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4621000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,831000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,831000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3790000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3790000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3790000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,137000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3927000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.07
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.07
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,965186.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:16:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.07
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1940000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3173000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5113000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5113000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1215000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1215000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6328000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6328000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6328000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,137000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6465000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.59
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.59
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,981644.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:46:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.59
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3287000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2399000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5686000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5686000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5062000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5062000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10748000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10748000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10748000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,139000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10887000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1006893.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:56:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3594000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3156000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6750000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6750000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3532000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3532000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,37000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10319000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4955760.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3612000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5370000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8982000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8982000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2311000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2311000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23717393.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5167000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6676000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11843000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11843000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23893651.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 11:04:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4944000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8230000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13174000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13174000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24325166.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:21:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6380000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9593000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15973000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15973000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-528000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-528000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24086651.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8023000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11618000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19641000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19641000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24600000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24600000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24602668.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7502000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10627000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18129000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18129000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-505000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-505000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18634000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,152000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18786000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18786000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18786000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25841530.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 10:55:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7462000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9904000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17366000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17366000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-523000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-523000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17889000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17961000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17961000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17961000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26061993.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 17:21:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7648000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12302000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19950000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19950000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-512000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-512000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20462000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-85000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25781230.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9801000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12309000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22110000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22110000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-548000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-548000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22658000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22704000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22704000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22704000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26723266.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9386000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13304000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22690000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22690000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-482000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-482000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23172000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,47000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23219000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23219000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23219000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26773337.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:41:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10627000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12688000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23315000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23315000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-460000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-460000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23775000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29380453.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 08:36:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14664000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14093000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28757000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28757000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-504000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-504000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29261000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29322000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29322000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29322000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29100000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29135583.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.87
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14475000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10954000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25429000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25429000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-312000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-312000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25741000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33900000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33777395.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17153000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10615000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27768000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27768000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-618000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-618000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28386000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,47000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28433000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28433000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28433000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34783195.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 17:54:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19774000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12408000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32182000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32182000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-141000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-141000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32323000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.89
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.89
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36210329.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.89
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5503000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38101000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16710000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60314000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60314000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-99000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-99000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60413000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1900000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-58513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.64
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.64
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35324472.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.64
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22930000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12972000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4893000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40795000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40795000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,96000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,96000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.05
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38800000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.05
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38598827.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.05
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2423000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2423000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2364000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39891000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18157000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58048000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55684000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,663000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,663000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55021000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55024000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55024000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55024000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.4
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.4
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39204762.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 17:54:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.4
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7302000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7302000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,205000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,205000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7097000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39933000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28502000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68435000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61338000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24050000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24050000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.96
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.96
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43657423.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:08:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.96
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14456000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14456000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14079000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17860000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26492000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,21652000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66004000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51925000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,467000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,467000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.17
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41700000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.17
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41663958.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.17
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10852000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10852000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4838000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4838000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6014000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17884000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54166000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48152000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,111000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48041000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-90000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47951000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47951000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47951000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45200000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.06
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45200000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.06
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45270660.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.06
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15835000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15835000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,705000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,705000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15130000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34482000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20904000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5819000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61205000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46075000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1089000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1089000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.04
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45400000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.04
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45397024.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:49:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.04
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18544000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18544000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2063000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2063000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16481000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32171000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21796000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5841000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59808000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43327000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6075000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6075000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45300000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45448190.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:35:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.09
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24657000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24657000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-2773000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-2773000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27430000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35467000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30794000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11107000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77368000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-49938000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5126000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5126000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45500000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.2
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45500000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.2
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45427154.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.2
